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Abstract
A novel silicon-substituted phenylalanine derivative was prepared using the Strecker amino acid
synthesis. An unexpected oxidative cleavage was observed in the preparation of the aldehyde
required for the Strecker reaction. In this step, a homobenzylic alcohol intermediate was oxida-
tively cleaved to the corresponding benzaldehyde using either chromium or palladium based
oxidants. This undesired side reaction was overcome through the use of Dess-Martin Periodinane,
or through an efficient TEMPO-bleach oxidation. The amino acid prepared in this study was then
labelled with fluoride in aqueous solvent using a range of fluoride sources. The efficiency of this
labelling motivates future studies in late-stage fluorination of peptide and protein therapeutics for
use in positron emission tomography.
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1 | INTRODUCTION
Amino acids that can be labelled with [[18]F]-fluoride are important for
accessing peptides and proteins used in positron emission tomography
(PET).[1–9] Silicon-containing amino acids have emerged as useful resi-
dues in this context.[10] Among the more common strategies for [18]F
labelling at silicon is the isotopic exchange of Si-[19]F for Si-[18]F
(Scheme 1A).[2,10–13] This strategy benefits from good to excellent
radiochemical yields and rapid reactions—a necessity given the short
half-life of [18]F (110 min).[2,12,13] While this strategy has enabled a
number of impressive in vivo and pre-clinical studies,[2] the fluorination
is typically performed on prosthetic groups (rather than directly on
macromolecules) and the Si-F bond is susceptible to hydrolysis.[14] For
hindered Si-F groups (e.g., R5 i-Pr or t-Bu in Scheme 1), this hydrolysis
is slow and does not compromise PET applications carried out on time
scales shorter than the half-life of hydrolysis.[14] If, however, the amino
acid were incorporated into a macromolecule through a biosynthetic
route such as amber codon suppression or genetic code reassignment
techniques,[15–17] then the hydrolysis may become significant due to
the prolonged exposure to aqueous media required during the synthe-
sis and purification. Therefore, we thought it would be useful to con-
sider other silicon-based groups that are stable in water and react
efficiently with common fluoride sources. Accordingly, we examined
the synthesis and fluorination of silanol-substituted phenylalanine
derivative 1 (Scheme 1B). In the preparation of this novel amino acid,
we discovered some unexpected reactions in the oxidation of a homo-
benzylic alcohol intermediate. We also established that 1 is stable in
buffer and can be labelled directly with fluoride in aqueous media.
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2 | MATERIALS AND METHODS
Detailed protocols for all experiments, [1]H and [13]C NMR spectra, and
additional analytical characterization are provided in the Supporting
Information.
3 | RESULTS AND DISCUSSION
We planned to synthesize the novel amino acid (6)-1 using the
Strecker reaction[18–20]—a strategy used previously for related amino
acids.[10] This route would require key aldehyde intermediate 2, which
in turn could be obtained from the oxidation of the corresponding
homobenzylic alcohol 3. To install the silicon group intended as the site
for fluorination, a lithiation-silylation was envisioned, with the synthesis
beginning with arylbromide 4 (Scheme 2). In the long-term, we plan to
use 1 as a building block for peptides and proteins using biosynthetic
pathways. For this reason, the racemic amino acid was viewed as an
appropriate target because of the biosynthetic selectivity generally
observed for the incorporation of (L)-phenylalanine and its derivatives
over their enantiomers during ribosomal biosynthesis of peptides and
proteins.[21,22]
In the synthesis, alcohol 4 was first protected by reaction with
TBS-Cl to provide silyl ether 5 in 93% yield. Next the silicon group was
installed through lithium halogen exchange of 5 with n-BuLi, and subse-
quent reaction of the resulting aryllithium with diisopropylchlorosilane
which provided 6 in 94% yield. TBS removal under acidic conditions
gave alcohol 7 in 93% yield. Subsequent oxidation of the silane to the
silanol in a basic solution of water and methanol provided the key
homobenzylic alcohol intermediate 3 in 82% yield (Scheme 3). More
than 4.0 g of 3 was prepared by this route.
Up to this stage the synthesis had proceeded smoothly, but the
conversion of homobenzylic alcohol 3 to the aldehyde intermediate 2
proved to be an unexpected challenge. The use of pyridinium chloro-
chromate (PCC) resulted in the oxidative cleavage of the CAC bond
joining the benzylic and homobenzylic carbon atoms, providing benzal-
dehyde 8 as an undesired product (Scheme 4, Entries 1–4). While there
is precedence for chromium-based oxidative cleavage reactions of
homobenzylic alcohols,[23–26] we were still surprised by the high con-
versions observed for this unwanted reaction. For instance, up to 90%
conversion to the undesired benzaldehyde 8 was observed with excess
PCC (4 equivalents) within 6 hr of reaction time at room temperature
(Scheme 4, Entry 1). This result was curious given a previous report in
which a similar aldehyde was prepared using chromium based oxida-
tions under similar conditions without mention of this side reaction.[10]
Using two equivalents of PCC still resulted in a mixture of 2 and 8, and
using only one equivalent resulted in a mixture of aldehydes 2 and 8,
SCHEME 1 Silicon-containing amino acid residues are useful in the direct fluorination of peptides and proteins for PET imaging. A, Isotopic
exchange is a common strategy for installing [18]F into peptides and proteins. The Si-F group may hydrolyse slowly in water. B, An amino
acid labelled with a silanol is proposed in this study as an alternative group that can be labelled directly with a fluoride source such as HF.
The proposed target 1 was expected to be stable to aqueous media, which may be useful if it is incorporated into peptides and proteins
using a biosynthetic pathway
SCHEME 2 Retrosynthetic analysis of (6)-1
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as well as unreacted alcohol 3 (Scheme 4, Entries 3–4). While the
mechanistic details for the oxidative conversion of homobenzylic alco-
hols to benzaldehydes have not been studied,[23–26] we suspect that
the homobenzaldehyde is an intermediate in the process. For instance,
treating purified 2 with 1 equivalent of PCC resulted in the formation
of 8 (see page S23 in the Supporting Information). This result confirms
the hypothesis that homobenzaldehyde 2 can be an intermediate in the
conversion to 8 and that this oxidative cleavage also applies to homo-
benzaldehydes. Pyridinium dichromate (PDC) also led to the unwanted
oxidative cleavage, providing the undesired benzaldehyde 8 in 85%
conversion after 3 hr of reaction at room temperature when 4 equiva-
lents of the oxidant were used (Scheme 4, Entry 5).
Interestingly, this oxidative cleavage was also observed when using
Uemura’s palladium catalysed aerobic oxidation,[27] with a 2:1 ratio of
2:8 observed by 1H NMR (Scheme 4, Entry 6). While unreacted starting
material was still the major product in this reaction (64% unreacted 3
was indicated by 1H NMR), the oxidative cleavage is still notable
because it was not reported in other studies on the palladium catalysed
SCHEME 3 The synthesis of alcohol intermediate 3
SCHEME 4 When using either chromium or palladium-based oxidants, alcohol 3 was converted to a mixture of the desired aldehyde 2 and
the undesired benzaldehyde 8. Using either Dess-Martin Periodinane (DMP) or TEMPO/NaOCl as oxidants prevented the undesired oxida-
tive cleavage reaction and both methods provided 2 in good yields. Product distributions were determined directly by 1H NMR spectros-
copy for Entries 1–7 and isolated yields are reported for Entries 8–10
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aerobic oxidation of homobenzylic alcohols,[28–33] so this transforma-
tion may be dependent on the specific catalyst system. In any case, this
is the only example of which we are aware where Uemura’s aerobic
oxidation leads to oxidative cleavage of a carbon–carbon bond for
homobenzylic alcohols. We also note that similar oxidative cleavage
was observed with the substrate 2-phenylethanol when using either
Uemura’s oxidation or PCC, so the silicon group is not required for this
transformation (see pages S24–S25).
It is important to note that even small amounts of 8 are incon-
venient because it was challenging to separate 2 and 8 by column
chromatography. Therefore, we turned to other oxidations to over-
come the unwanted CAC cleavage. Dess-Martin Periodinane
(DMP)[34] did not provoke the oxidative cleavage, though the reac-
tion was sluggish with only 54% of the desired aldehyde 2 formed
after 18 hr with 1.5 equivalents of DMP. When using four equiva-
lents of DMP, full conversion was observed after 18 hr and 2 was
isolated in a 70% yield. Shorter reaction times with four equivalents
of DMP resulted in slightly lower yields, with 2 isolated in 60%
yield after 1.5 hr (Scheme 4, Entry 9). This protocol was important
in providing pure 2, but we considered that the excess DMP
required and the low atom economy of the oxidation were not ideal
for up-scaling. Therefore, the key oxidation was also tested using
TEMPO and sodium hypochlorite.[35] Gratifyingly, this oxidation was
highly efficient and provided aldehyde 2 in 70% yield after only 25
min of reaction time at <108C (Scheme 4, Entry 10). The tempera-
ture of the reaction mixture was controlled to avoid decomposition
of oxoammonium intermediate derived from TEMPO,[35] and the
reaction progression was monitored carefully so that it could be
quenched before overoxidation to the corresponding acid. Even with
these precautionary measures, we note that this oxidation is opera-
tionally simple, rapid and high yielding. This outcome should encour-
age future use of the TEMPO and sodium hypochlorite oxidants in
the synthesis of homobenzylic aldehydes, including those advanced
to various phenylalanine derivatives through the Strecker reaction.
The synthesis of (6)-1 was completed using the Strecker reaction
in which aldehyde 2 was first reacted with sodium cyanide, ammonium
hydroxide and ammonium chloride to form amino nitrile 9, which was
used directly without purification. Hydrolysis of the crude amino nitrile
9 under basic conditions, followed by purification by ion exchange
chromatography provided the target compound as a crystalline solid
(Scheme 5).
While the yield of 1 after the Strecker sequence and ion exchange
chromatography was relatively low (24% in the conversion of 2 to 1),
more than 1.0 g of 1 was prepared. With this quantity in hand, we
could study the reaction of 1 with various fluoride sources. To obtain a
benchmark, HFPyridine was tested first in its reaction with 1 in reflux-
ing methanol. Gratifyingly, after 2 hr, full conversion to 10 was
observed (Scheme 6). This result was encouraging in that the fluorina-
tion occurred readily even in a protic solvent that could hydrogen bond
to fluoride and potentially attenuate its reactivity.
Next, the fluorination was tested with a variety of fluoride sources
using aqueous DMSO or buffers as solvent (Scheme 7). HFPyridine
was tested first using a 3:1 ratio of DMSO:D2O by volume and the
reaction temperature was set to 958C. Full conversion of 1 to 10 was
observed within 2 hr, as indicated by both [1]H and [19]F NMR spectros-
copy (Scheme 7, Entry 1). The formation of the SiAF bond was consist-
ent with a signal at 2182.15 ppm in the [19]F NMR spectrum. The [1]H
NMR spectrum of 1 and 10 were also easily resolved with significant
differences in chemical shift for the signals corresponding to the aro-
matic and isopropyl protons. This distinction allowed calculation of
reaction conversions where mixtures of 1 and 10 were formed
(Scheme 7). Pleasingly, full conversion was also observed at 378C under
otherwise identical conditions (Scheme 7, Entry 2). Successful fluorina-
tion at the lower temperature is important if this reaction is to be
adapted to proteins. Perhaps just as important, the fluorination of 1
was also possible using a solution of HF in water, with only 10% vol-
ume of DMSO in the reaction mixture. For fragile proteins that are
incompatible with high levels of organic solvents, this is an important
SCHEME 5 The Strecker reaction provided the target amino acid (6)-1
SCHEME 6 The fluorination of 1 in methanol
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capability. When the reaction was buffered (either at pH 4 or pH 8),
slightly lower conversions of 60 and 58% were observed in the respec-
tive fluorination (Scheme 7, Entries 4–5), but this is still substantial
labelling in the context of PET. It should also be noted that in buffered
media, the addition of 10% DMSO as a co-solvent helped keep 1 in
solution. However, over the course of these buffered reactions the
amino acid precipitated, which could account in part for the lower con-
versions. Finally, KF was examined as a fluoride source. At pH 4, 38%
conversion was observed after 2 hr at 958C (Scheme 7, Entry 6). Nota-
bly, no DMSO was used in this experiment. While this conversion was
lower than the other reactions examined in Schemes 6 and 7, it was
notable that KF could be used directly, without the need for the crypt-
and Kryptofix222, which is commonly used to bind to potassium ions
and make the fluoride more nucleophilic.[36] Additionally, the successful
fluorination using HF or KF is important because both can be formed
directly from the [[18]F]-fluoride produced for PET imaging.[36]
The direct labelling of an amino acid with fluoride in aqueous
media, as demonstrated in Scheme 7, is noteworthy because it is far
more common to react [[18]F]-fluoride with a silicon-containing reagent
in an organic solvent and then ligate that reagent to a peptide or pro-
tein in a second step.[2,37–42] There are far fewer examples of labelling
proteins with [[18]F]-fluoride directly at a well-defined site, in aqueous
buffer, and in the final step. In these rare cases, the fluoride reactive
group is typically ligated to the protein as a prosthetic group before flu-
orination.[43] In contrast, genetically encoded incorporation of 1 would
provide the fluoride reactive group directly on the protein during bio-
synthesis. Labelling such a peptide or protein with [[18]F]-fluoride in the
final step may also be useful in obtaining higher radiochemical yields
because only one reaction and purification would be required, as
opposed to multi-step reactions that require precious time over which
the radioisotope decays. The results in Schemes 6 and 7 suggest that 1
is worth exploring in this context. Accordingly, we are currently investi-
gating methods to biosynthetically incorporate amino acid 1 into
peptides and proteins, for direct labelling with [[18]F]-fluoride in the
final step. We anticipate such capabilities will find ultimate use in the
synthesis of peptides and proteins that can be imaged by PET.
4 | CONCLUSIONS
The gram-scale synthesis of a novel amino acid (6)-1 was accom-
plished. This amino acid contains a silanol group that can be labelled
with multiple fluoride sources with useful conversions—even when
water is the primary solvent. This capability motivates future explora-
tion in the genetic incorporation of 1 into peptides and proteins for
subsequent [[18]F]-labelling and use as tracers in PET imaging. In the
synthesis of (6)-1, an undesired oxidative cleavage of a homobenzylic
alcohol was discovered when using either chromium or palladium-
based oxidants. This side reaction was so efficient in certain cases (e.g.,
>90% conversion was observed with four equivalents of PCC) that it
might find use as a synthetic method in other contexts. The oxidative
cleavage using palladium is notable because this type of transformation
has not been reported for this catalyst system. Using either DMP or a
TEMPO/NaOCl oxidant overcame this unwanted oxidative cleavage
and provided a convenient route to the required aldehyde. These oxi-
dation protocols may be also useful in the synthesis of other phenylala-
nine derivatives prepared via the Strecker method.
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